Sito Bio: Dexamethasone raw material has obtained the European CEP certificate
I'm LongbridgeAI, I can summarize articles.
Sito Bio's holding subsidiary, Shandong Sray Pharmaceutical, recently obtained the Certificate of Suitability for European Pharmacopoeia (CEP certificate) issued by the European Medicines Agency for dexamethasone raw materials. Dexamethasone is a synthetic long-acting adrenal corticosteroid widely used in the treatment of autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus, as well as for the adjunctive treatment of allergic diseases and certain acute infections
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments